Contribution: Industrial Research Assistance Program – Contributions to Firms

Biomolecules for life Inc.

$71,275.00

Purification of an active ingredient for the development of a targeted cancer therapy

FY 2021-22 · 2021-05-31

Summary

This project aims to develop a set of extraction and purification methods to obtain an active principle, which will be used in the development process of a targeted therapy for cancer.

Department

National Research Council Canada

Program

Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)

Recipient

Biomolecules for life Inc.

Location

Moncton|Moncton, New Brunswick, Canada

Recipient Type

For-profit organization

Business Number

831651336

Type

Contribution

Source

Proactive Disclosure - Grants and Contributions

Amendments

Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.

Amendment	Date	Fiscal Year	Total
0	2021-05-31	2021-22	$29,640.00
1	2021-05-31	2021-22	$29,640.00
2	2021-05-31	2021-22	$71,275.00
3	2021-05-31	2021-22	$71,275.00

As published

Additional Information

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 213 days.

Additional Information (French)

Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 213 jours.

Agreement End Date

2023-03-01

Agreement Number

973093

Agreement Start Date

2021-05-31

Agreement Title

Purification of an active ingredient for the development of a targeted cancer therapy

Agreement Title (French)

Purification d’un principe actif pour fin de développement d’une thérapie ciblée pour le cancer

Agreement Type

Contribution

Agreement Value

$71,275.00

Amendment Date

2022-09-22

Amendment Number

Coverage

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.

Description

This project aims to develop a set of extraction and purification methods to obtain an active principle, which will be used in the development process of a targeted therapy for cancer.

Description (French)

Ce projet vise à développer un ensemble de méthodes d’extraction et de purification pour obtenir un principe actif, lequel sera utilisé dans le processus de développement d’une thérapie ciblée pour le cancer.

Expected Results

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Expected Results (French)

Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation

Federal Riding

Moncton--Riverview--Dieppe

Federal Riding (French)

Moncton--Riverview--Dieppe

Federal Riding Number

13007

NAICS Code

541710

Organization Code

nrc-cnrc

Organization

National Research Council Canada | Conseil national de recherches Canada

Program Name

Industrial Research Assistance Program – Contributions to Firms

Program Name (French)

Programme d’aide à la recherche industrielle – Contributions aux entreprises

Program Purpose

Program Purpose (French)

Recipient Business Number

831651336

Recipient City

Moncton|Moncton

Recipient Country

Recipient Legal Name

Biomolecules for life Inc.

Recipient Postal Code

E1C 5R2

Recipient Province or Territory

Recipient Type

Reference Number

172-2021-2022-Q1-973093

View source data Proactive Disclosure - Grants and Contributions (Treasury Board of Canada Secretariat)